Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 55 (12%) | |
| Anticipated shortage: | 14 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 368 (83%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
13 (17%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLARITHROMYCIN | 125MG | GRANULES FOR SUSPENSION | Resolved | 2022-07-27 | 2024-03-02 | 165567 |
| AMOXICILLIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-10-20 | 2024-02-14 | 172266 |
| AMOXICILLIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-11-08 | 2024-02-14 | 173943 |
| CIPROFLOXACIN | 250MG | TABLET | Resolved | 2022-12-16 | 2023-01-23 | 178647 |
| RISEDRONATE | 35MG | TABLET | Resolved | 2023-03-16 | 2024-02-29 | 187292 |
| CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-03-16 | 2024-03-02 | 187295 |
| MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-03-16 | 2023-05-04 | 187300 |
| SNS-ASA EC | 80MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-03-16 | 2023-09-10 | 187303 |
| FUROSEMIDE | 80MG | TABLET | Resolved | 2023-03-16 | 2023-07-06 | 187306 |
| FUROSEMIDE | 20MG | TABLET | Resolved | 2023-03-16 | 2023-07-06 | 187311 |
| ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-06-22 | 2023-08-08 | 196099 |
| ROSUVASTATIN | 10MG | TABLET | Resolved | 2023-06-22 | 2023-09-06 | 196102 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2023-06-27 | 2023-11-13 | 196716 |
| ATENOLOL | 50MG | TABLET | Resolved | 2023-06-27 | 2023-10-10 | 196720 |
| LEFLUNOMIDE | 10MG | TABLET | Resolved | 2023-07-05 | 2023-09-25 | 197620 |
| LEFLUNOMIDE | 20MG | TABLET | Resolved | 2023-07-05 | 2023-11-06 | 197624 |
| MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-07-05 | 2024-01-30 | 197632 |
| CEPHALEXIN | 250MG | TABLET | Resolved | 2023-07-14 | 2024-03-08 | 198742 |
| CEPHALEXIN | 500MG | TABLET | Resolved | 2023-07-14 | 2023-12-26 | 198745 |
| SILDENAFIL | 100MG | TABLET | Resolved | 2023-07-17 | 2023-09-19 | 198785 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| TERAZOSIN | 10MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151275 |
| TERAZOSIN | 1MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151278 |
| TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
| TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| DILTIAZEM CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2412 |
| DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| LORAZEPAM | 0.5MG | TABLET | Reversed | 2017-03-14 | 2017-07-31 | 2430 |
| CLINDAMYCIN | 150MG | CAPSULE | Reversed | 2017-03-31 | 2017-07-31 | 4950 |
| CLINDAMYCIN | 300MG | CAPSULE | Reversed | 2017-03-31 | 2017-07-31 | 4956 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |
| INDAPAMIDE | 1.25MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2453 |
| RAMIPRIL-HCTZ | 12.5MG 10.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3023 |